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Abstract
Background: There is a significant need for affinity reagents with high target affinity/specificity that can be developed
rapidly and inexpensively. Existing affinity reagent development approaches, including protein mutagenesis, directed
evolution, and fragment-based design utilize large libraries and/or require structural information thereby adding time and
expense. Until now, no systematic approach to affinity reagent development existed that could produce nanomolar affinity
from small chemically synthesized peptide libraries without the aid of structural information.
Methodology/Principal Findings: Based on the principle of additivity, we have developed an algorithm for generating high
affinity peptide ligands. In this algorithm, point-variations in a lead sequence are screened and combined in a systematic
manner to achieve additive binding energies. To demonstrate this approach, low-affinity lead peptides for multiple protein
targets were identified from sparse random sequence space and optimized to high affinity in just two chemical steps. In one
example, a TNF-a binding peptide with Kd=90 nM and high target specificity was generated. The changes in binding
energy associated with each variation were generally additive upon combining variations, validating the basis of the
algorithm. Interestingly, cooperativity between point-variations was not observed, and in a few specific cases, combinations
were less than energetically additive.
Conclusions/Significance: By using this additivity algorithm, peptide ligands with high affinity for protein targets were
generated. With this algorithm, one of the highest affinity TNF-a binding peptides reported to date was produced. Most
importantly, high affinity was achieved from small, chemically-synthesized libraries without the need for structural
information at any time during the process. This is significantly different than protein mutagenesis, directed evolution, or
fragment-based design approaches, which rely on large libraries and/or structural guidance. With this algorithm, high
affinity/specificity peptide ligands can be developed rapidly, inexpensively, and in an entirely chemical manner.
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Introduction
A comprehensive survey of the human proteome requires a vast
library of specfic affinity reagents [1–4]. Building such a library
requires strategies that are high-throughput, inexpensive and have
the flexibility to produce ligands that are compatible with
numerous applications such as gel-based analysis, histology,
microarrays, purification columns, etc. [4]. Several well-estab-
lished approaches have proven to be a rich source of affinity
reagents. These include in vitro selection of peptides [5–7], protein
mutagenesis [8], computational design [9–12], aptamer selection
[13], bead-based library screens [14], and fragment-based design
of small molecules [3]. While these approaches generally produce
high-quality affinity reagents, they don’t fully meet the need for
rapid development, low cost, and application-specific flexibility.
The utilization of large chemical libraries during several stages of
affinity reagent development and/or the need for structural
information extend the completion time, increase the cost, and
limit the flexibility with these approaches [3,8,15,16]. A new
approach that addresses these points would have the potential to
serve the need for large numbers of inexpensive affinity reagents
for proteomics.
Driven by this need, we have explored a fundamentally
different, systematic strategy to develop high affinity binders to a
given protein target. Our guiding hypothesis was that weak
binding lead peptides could be readily identified from a screen of a
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15432small chemical library of unstructured short random peptide
sequences. Once identified, these leads could then be systemati-
cally improved to high affinity by utilizing thermodynamic
additivity of sequence variations. If successful, such an algorithm
would be generally applicable and enable high-throughput, low-
cost production of peptide affinity reagents with significant
flexibility due to the fact that the process is based solely on
chemical synthesis of small libraries, rather than large enzymat-
ically generated libraries. Importantly, because the algorithm relies
on additive interactions, it does not require structural knowledge
about the target. This is a principal characteristic that differen-
tiates this algorithm from other approaches that try to identify
cooperative interactions, which frequently require structural
information about the target protein and possibly the affinity
reagent/target complex [3,9], thereby significantly reducing
throughput and increasing cost. Here, we test the concepts of
this algorithm by generating high affinity peptide ligands to
protein targets.
In addition to the practical aspects of such an algorithm, the
effects of sequence perturbation(s) on protein-peptide binding
thermodynamics and specificity with short peptides derived from
random chemical libraries remains largely unexplored. Protein-
protein and protein-small molecule binding thermodynamics have
been extensively studied [17–21], but due to their highly
structured nature, it is not obvious that the same energetic
behavior observed in these complexes can be expected with short
unstructured peptides. In a protein-protein or protein-small
molecule complex, the overall binding energy can be an additive
or non-additive accumulation of component free energies, or a
combination of additive and non-additive effects. Additivity of
component free energies is observed when the component
interactions do not structurally interact and contribute indepen-
dently to the standard free energy of binding [22]. Conversely,
non-additive cooperative contributions to binding free energy are
observed when individual components are structurally connected.
The work presented here provides insight into the additive/non-
additive protein binding thermodynamics and specificity of
sequence variations in short unstructured peptide ligands identi-
fied from random chemically-synthesized sequence space.
Results
The basic strategy is illustrated in Figure 1. We choose to test
this strategy by creating ligands to the cytokine, tumor-necrosis
factor alpha (TNF-a) [23–25]. TNF-a is a high-value target for
which several antibody and small molecule therapeutics have been
developed [26,27]. TNF-a affinity reagents have been isolated by
other procedures [28–30], and this is useful for comparison. If
successful, a ligand for TNF-a could be used as an affinity reagent
by itself or as a component of a multivalent ligand [31].
Lead Generation from a Sparse Random Library
A library of 10
4 random 20-mer peptides (17 randomized
positions, 3 fixed positions at the C-terminus) was screened in
order to generate lead peptides with affinity for TNF-a. 20-mer
peptides were chosen because they are not expected to adopt
stable structures that would interfere with the ability of different
residues in the peptide to bind independently (Figures S1-3 in File
S1). Preliminary microarray experiments showed that this library
contains sufficient chemical diversity to identify lead peptides with
measurable target binding affinity and specificity (CWD and SAJ
unpublished data). This is likely possible because only a few
favorable contacts between a peptide and a target protein are
needed for observable binding [32].
Each member of this library of 10
4 peptides was individually
screened by surface plasmon resonance (SPR) and 171 peptide
sequences were identified as potential leads with affinity for TNF-
a. The significant number of potential lead sequences allowed for
the application of more stringent lead criteria such as good
solubility, high peptide sample purity and low background binding
to the SPR chip surface. To minimize non-specific binding, the
number of potential leads was further reduced by comparing
TNF-a SPR binding response to a panel of four unrelated proteins
(AKT1, Neutravidin, Transferrin, and Ubiquitin). Two peptides,
FERDPLMMPWSFLQSRQGSC (referred to as TNF1, note that
the GSC sequence at the end was common to all peptides in the
library) and YGPSDAFKITRFHQQSSGSC (referred to as
TNF4) were chosen as lead peptides for optimization based upon:
their respective dissociation constants (Kd) of 160619 mM and
Figure 1. Schematic of the additivity algorithm. A) A lead sequence is first identified from a peptide library; this algorithm is not dependent on
the source of the initial library (i.e. chemical library, in vitro library, etc.). B) A small library of point-variants (X= any substitution) is synthesized to C)
identify substitutions that enhance target affinity. D) Enhanced point-variants are combined to produce a peptide with a relative binding free energy
approximately equal to the sum of the component energies.
doi:10.1371/journal.pone.0015432.g001
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S4 in File S1); and their relative solubility indicated by
average hydropathy (GRAVY)[33] scores of 20.52 and 20.77,
respectively.
Point-Variant Scanning of the TNF1 Lead Peptide
A small library of TNF1 point-variants was generated to identify
higher affinity peptides. For a 20-residue peptide, it is feasible to
synthesize many, if not all, of the possible point-variants by
standard commercial synthesis and screen them individually. In
this study, only a subset of amino acids was substituted at each
position in TNF1, making the number of peptides in the library
more manageable. The specific amino acids used were selected
based on data from previous protein interaction studies [34–38]. A
library of TNF1 point-variants containing all substitutions of the
amino acid set {Y, A, D, S, K, N, V, W} in each of the 17
randomized positions (132 unique point-variants) was synthesized.
Tyrosine (Y), alanine (A), aspartic acid (D) and serine (S) were
selected because of their effectiveness in producing high affinity
interactions when substituted into the complementary-determining
regions (CDRs) of synthetic antibodies [34], lysine (K) was selected
to balance the charge in the substitution set, asparagine (N), valine
(V) and tryptophan (W) were selected to span the hydropathy
range [33]. This set of 132 point-variants was screened for relative
TNF-a SPR binding response using a 50 mM peptide concentra-
tion in each case. This concentration is approximately 3-fold
below the Kd of TNF1, and was used in order to increase the high-
end dynamic range for quantifying enhancing point variations.
The results from the TNF1 point-variant screen are represented
as a heat map (Figure 2). The heat map reveals that variations at 9
unique positions in the sequence result in a greater than 10-fold
increase in the SPR binding response relative to TNF1. Most
notably, the heat map suggests that negative charges in the lead
peptide may decrease TNF-a binding; almost any variation in
position 2 (E) or 4 (D) enhances affinity, including alanine, which is
considered a neutral substitution in scanning mutagenesis [39].
Further support for the importance of the overall charge of the
peptide comes from the fact that substituting lysine in several
positions enhances affinity. This suggests that the optimized
peptide should have a higher pI than TNF1. In addition to the
effects of negative charge, the heat map indicates that tyrosine is a
particularly favorable substitution in the N-terminal half of the
peptide. Tyrosine is the most favorable uncharged substitution in
the point-variant library, with 7 out of the 17 positions substituted
with tyrosine producing better than 5-fold enhancement. This is in
agreement with protein mutagenesis studies that show tyrosine to
be the most effective amino acid for producing favorable protein-
protein interactions [34–38]. Also, affinity enhancement from
tyrosine or lysine substitution in several positions of the peptide is
consistent with the idea that, in mostly unstructured peptides,
modest affinity can be achieved from a few interacting residues
separated by relatively flexible non-interacting residues.
Five of the affinity-increasing point-variants (D4S, D4Y, P5Y,
M7K, S11K) were selected for further characterization because
they showed a $15-fold enhancement in SPR binding response
relative to TNF1 as well as low non-specific binding on the SPR
chip. TNF-a affinities (Kd) for the selected point-variant sequences
were determined by equilibrium SPR measurements (Table 1).
Consistent with the initial point-variant screen, the selected
variants have significantly higher affinity than TNF1, exhibiting
an average 3.4 fold Kd improvement.
Affinity Prediction of TNF1 Multiple Variants
Relative binding free energies for each point variation were
calculated as the difference between the standard free energy of
binding for the point-variant sequence and that of the lead
sequence. The resulting relative binding free energies for the D4S,
D4Y, P5Y, M7K and S11K variants are given in Table 1. From
these individual contributions and the assumption that combining
point variations would result in a sum of their relative binding free
energies, the binding free energies of variant sequences containing
multiple substitutions can be predicted.
Thus, a combination of 4 point variations (D4S+P5Y+M7K
+S11K) is predicted to have a Kd ,1 mM, an approximate 100-
fold improvement relative to the lead peptide (Kd=160 mM). As a
result of these predictions, this quadruple variant, referred to as
TNF1-opt, was selected as the optimized sequence. The D4S
substitution was selected over the D4Y substitution because a
Figure 2. Fold-change heat map from the SPR screen of TNF1 point-variants. Fold-change relative to the TNF1 lead peptide was calculated
from an average binding response after a 60-second association across several replicate injections of a fixed 50 mM peptide concentration. Peptides
were assayed at a concentration well below the dissociation constant of the lead peptide (Kd ,160 mM) to improve the high-end dynamic range of
responses. Point variation nomenclature: ‘P6Y’, indicates the original proline in position 6 is substituted with a tyrosine in the corresponding variant
peptide.
doi:10.1371/journal.pone.0015432.g002
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improvement, which suggests there may be a proximity effect of
tyrosine substitution in this region of the peptide. In other words, it
may be that tyrosine can produce an affinity enhancement in
either position 4 or 5 but not both positions, particularly given the
large size of tyrosine. Therefore, a serine substitution was used in
position 4 (D4S) and tyrosine in position 5 (P5Y). In addition to the
TNF1-opt quadruple variant, several intermediate variants
(double, triple variants) were characterized to compare predicted
affinities to observed TNF-a affinities.
Affinity Characterization of TNF1 Double, Triple and
Quadruple Variants
Four double (D4Y+M7K, D4Y+S11K, P5Y+M7K, P5Y+
S11K), two triple (D4S+P5Y+M7K, D4S+P5Y+S11K) and one
quadruple (D4S+P5Y+M7K+S11K) variant sequences were
characterized with SPR. In all cases, an improvement in TNF-a
affinity was observed when an additional enhancing substitution
was added to the sequence. Double variants had higher affinities
than the corresponding single variants, triple variants had higher
affinities than the corresponding single/double variants and the
quadruple variant had the greatest affinity (Figure 3, Table 2).
The optimized quadruple variant sequence (TNF1-opt) has a
Kd=1.660.3 mM determined by equilibrium SPR measurements
(Figure 4, Figures S5, S6 in File S1). Further validation of TNF1-
opt affinity was performed using fluorescence anisotropy, resulting
in a Kd=1.160.2 mM, in agreement with the affinity determined
by SPR (Figure 4).
Kinetic fits of the TNF1 and TNF1-opt SPR sensorgrams (Figure
S7 in File S1)indicate that TNF1-opt has approximately an order of
magnitude or more improvement in both on-rate (kon), and off-rate
(koff), when compared to TNF1 (TNF1: koff=1.660.5 s
21,
kon=5.061.7610
3 M
21s
21, TNF1-opt: koff=0.260.02 s
21 kon=
2.660.2610
5 M
21s
21). From these rate constants, one can
calculate a Kd of 0.7060.02 mM for TNF1-opt, which is
comparable to the affinities determined from equilibrium SPR
binding responses and fluorescence anisotropy (Figure 4).
Comparison of TNF1 Multiple Variant Observed Affinities
to Predicted Affinities
When the standard free energy of binding determined from the
Kd of the lead peptide, TNF1, is added to the sum of the relative
free energies of the individual point-variants required to generate
TNF1-opt, a predicted Kd of 1.9–0.7 mM is obtained (Table 2).
This matches well with the observed TNF1-opt Kd of 1.660.3 mM
and suggests that the affinity enhancements contributed by each of
the four point variations in TNF1-opt are acting nearly inde-
pendently [22]. If the energetic contributions of point variations
are additive, then a plot of the observed vs. predicted binding
energies for the multiple variants should have a slope of 1
(Figure 5). The slope of the best-fit line for the variants tested is
0.9760.01, very close to the expected value. Detailed predicted
and observed values for each of the variants tested are given in the
supporting materials (Table S1 in File S1) and in almost every
case, nearly additive energetic contributions of the point variations
are observed. The variant sequence that deviates most from the
predicted value is the D4S+P5Y+M7K triple variant. In this case
there are three substitutions in close proximity that could result in
nearest neighbor interactions that alter the energetic picture [20].
Combining the S11K variant, a three-residue separation from the
nearest substitution, with these three proximal substitutions
contributes additively.
Effect of TNF1 Additive Affinity Optimization on Binding
Specificity
In order to compare relative binding specificity of TNF1 and
corresponding variants, the peptides were spotted as a microarray
and TNF-a binding was tested in the presence of E.coli cell lysate.
Table 1. TNF1 lead and point-variant binding energies and affinities.
a
Peptide TNF1 Lead D4S D4Y P5Y M7K S11K
Standard Binding
DGu (kcal/mol)
25.2160.07 25.9860.04 25.9560.06 25.7960.04 25.9360.20 26.0360.10
Kd (mM) 160±19 42±2.4 44±4.8 58±3.4 57±20 40±7.2
Kd Fold-Change
Relative to Lead
-3 . 8 60.5 3.660.6 2.760.4 2.861.0 3.960.9
Variant Relative DG
Contribution (kcal/mol)
- 20.7760.08 20.7460.10 20.5860.08 20.7260.22 20.8260.13
aStandard binding free energies and dissociation constants (Kd) were calculated separately as an average of several replicate measurements. Point-variant relative
contributions were calculated as the difference between the standard binding free energy of a particular point-variant from that of the lead.
doi:10.1371/journal.pone.0015432.t001
Figure 3. Fold-change in TNF-a affinity across four generations
of TNF1 variant sequences. Fold-change relative to TNF1 is above the
bars in bold and is calculated from the association constant (Ka=1/K d)o fa
variant divided by the Ka of TNF1.
doi:10.1371/journal.pone.0015432.g003
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TNF-a binding specificity across all variants in a single
experiment. Preliminary microarray studies indicated that E.coli
cell lysate serves as an excellent heterogeneous competitor (PEB,
CWD and SAJ unpublished data). To minimize dye effects on
binding, dual-color dye-swap experiments were performed with
Alexa-555 labeled TNF-a and Alexa-647 labeled E.coli lysate, then
repeated under the same conditions with Alexa-647 labeled TNF-
a and Alexa-555 labeled E.coli lysate. These data were normalized
and the TNF-a/E.coli binding intensity ratios for TNF1 and
corresponding variants calculated.
Binding intensity ratios on the microarrays show some increased
variant peptide binding to E.coli lysate relative to TNF1 (Table S2
in File S1). TNF1-opt, when spotted on a surface, binds both
labeled TNF-a and labeled E.coli lysate with greater apparent
affinity.
Subsequent pull-down assays were performed with TNF1 and
TNF1-opt immobilized on agarose beads in order to determine if
the increased TNF1-opt E.coli lysate binding is due to general non-
specificity or specific binding to a small number of E.coli proteins.
TNF-a was spiked into an excess of E.coli lysate and incubated
with the beads. SDS-PAGE analysis of the final eluted fraction
shows that both TNF1 and TNF1-opt have good specificity for
TNF-a (Figure 6). Only one additional band at approximately
65 kDa on the gel appears in the TNF1-opt eluted fraction when
compared to TNF1. Several faint bands above and one below the
Figure 4. Equilibrium binding isotherms for TNF1-opt. Outer
plot: SPR normalized replicate responses performed with TNF-a
captured on the SPR chip surface and variable TNF-opt concentrations
flowed over the surface. Inset plot: Solution-phase fluorescence
anisotropy measurements performed in triplicate with TNF1-opt labeled
at the C-terminal cysteine, TNF-opt concentration was fixed at 100 nM
while TNF-a concentration was varied. TNF1-opt sensorgrams are
available in Figure S5 in File S1, SPR binding isotherms for all enhanced
variants tested are available in Figure S6 in File S1.
doi:10.1371/journal.pone.0015432.g004
Table 2. TNF1 multiple variant observed/predicted binding energies and affinities.
a
Peptide D4Y+M7K D4Y+S11K P5Y+M7K P5Y+S11K
D4S+P5Y
+M7K
D4S+P5Y
+S11K
D4S+P5Y
+M7K
+S11K
Observed Standard Binding
DGu (kcal/mol)
26.5460.07 26.8760.05 26.2460.04 26.3160.04 26.6360.04 27.0360.04 27.9760.11
Kd (mM) 17±1.9 9.3±0.7 27±1.8 24±1.4 14±1.0 7.0±0.5 1.6±0.3
Kd Fold-Change
Relative to Lead
9.461.6 1762.5 5.860.8 6.660.9 1161.6 2363.2 100622
Predicted Standard Binding
DGu (kcal/mol)
-6.6660.25 -6.7760.18 -6.5160.24 -6.6160.17 -7.2860.26 -7.3860.19 28.1060.29
Kd Range (mM) 20-8.5 15-8.0 25-11 19-11 7.0-3.0 5.3-2.8 1.9-0.7
aStandard binding free energies and dissociation constants (Kd) were calculated separately as an average of several replicate measurements. Predicted standard binding
free energies were calculated as a sum of the standard binding free energy of the lead and the relative binding free energy contribution of the point-variations (Table 1)
substituted into the corresponding multiple variant sequences.
doi:10.1371/journal.pone.0015432.t002
Figure 5. TNF1 multiple variant standard binding free energies:
observed vs. predicted assuming thermodynamic additivity.
Observed standard binding free energies were calculated from the
dissociation constants measured across several replicate experiments,
predicted standard binding free energies were calculated as the sum
of the standard binding free energy of TNF1 and relative binding free
energy contributions from the corresponding point-variants. The
95% confidence interval for the best-fit line (solid line) is shaded.
The observed slope (0.9760.01) of the best-fit line is in good
agreement with the slope predicted from thermodynamic additivity
(predicted =1).
doi:10.1371/journal.pone.0015432.g005
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ed peptide, and are attributed to E.coli lysate binding to the
beads (Figure 6). From this result, the increased TNF1-opt E.coli
lysate binding observed on the microarray appears to be due
primarily to enhanced binding to a single E.coli protein. Qu-
antitative interpretation of this specificity data is somewhat difficult
due to avidity on the surface, which can favor non-specific
interactions [40].
Additive Optimization of a Second Lead Peptide (TNF4)
that Binds TNF-a
To test if this approach can be used to optimize lead peptides
with a much better starting affinity, TNF4 (Kd=2363.5 mM for
TNF-a) was optimized. From a screen of point-variants (Figure S8
in File S1), three affinity enhancing variations Y1W, D5Y and
T10Y having the respective affinities Kd=380680 nM,
Kd=280640 nM and Kd=310610 nM (Table S3 in File S1)
were identified. From these point-variants, a double variant
Y1W+D5Y with a Kd=200630 nM and a triple variant
Y1W+D5Y+T10Y (referred to as TNF4-opt) with a Kd=
90620 nM were produced (Table S3 in File S1). TNF4-opt has
an approximate 250-fold enhancement in affinity relative to the
TNF4 lead, which represents a larger affinity enhancement with
three substitutions in TNF4-opt compared to four substitutions in
TNF1-opt. This larger enhancement in TNF4-opt is thought to be
due to the fact that the point-variants exhibit a more than 70-fold
average enhancement relative to TNF4 (Table S3 in File S1)
compared to a 3.4-fold average enhancement in the TNF1 point-
variants (Table 1). TNF4-opt binding kinetic fits of SPR
sensorgrams across several concentrations (Figure S9 in File S1)
produce a koff=7.560.8610
23 s
21 and kon=5.861.2610
4 M
21s
21,
resulting ina Kd=130630 nM,which is in agreement with the affinity
determined from equilibrium binding responses. TNF-a pull-down
assays performed in the presence of excess E.coli lysate with TNF4 and
TNF4-opt immobilized on beads indicate good TNF-a binding
specificity (Figure S10 in File S1). After subtracting background bead
binding, TNF4-opt produces one additional off-target band in the
SDS-PAGE analysis when compared to TNF4.
General Applicability of the Additivity Algorithm
To explore the generality of thermodynamic additivity for
optimization of additional lead peptides and target proteins,
affinity optimization of a peptide with the sequence
AHKVVPQRQIRHAYNRYGSC (referred to as TRF26) known
to bind weakly to the common blood protein transferrin
(Kd=85614 mM) was performed. In this case, TRF26 was
identified from a screen of the same initial library of 10
4 random
peptide sequences printed as a microarray on a glass slide (PEB,
CWD and SAJ unpublished data), rather than high-throughput
SPR screening as was done for TNF1 and TNF4.
A library of 323 TRF26 point-variants, substituting 19 of the 20
natural amino acids (excluding cysteine) in 17 positions of the
peptide, was screened using array-based SPR with the peptides
immobilized on a gold SPR chip surface (via a C-terminal cysteine)
and 10 mM unlabelled transferrin in solution. The results of this
point-variant screen are shown as a heat-map (Figure S11 in File
S1). From this, two TRF26 point-variants (P6Y, H12F) were
selected for further affinity characterization. The P6Y and H12F
point-variants have dissociation constants of 8.661.6 mM and
9.761.6 mM respectively (Table S4 in File S1). Interestingly, a
substitution set of 19 amino acids in the TRF26 point-variant
screen did not produce proportionally more enhanced point
variations than the 8 amino acid set used in the TNF1 or TNF4
point-variant screens, which suggests that a large amino acid
substitution set is not required to identify affinity enhancing point
variations. A TRF26 double variant sequence containing the
P6Y+H12F variations was characterized by SPR. Assuming
energetic additivity of point variations, the P6Y+H12F variant
should have a Kd in the range of 1.3–0.7 mM. The observed
P6Y+H12F variant Kd=0.560.1 mM is in good agreement with
this prediction (Table S5 in File S1).
Discussion
We have utilized thermodynamic additivity of component
variations to formulate a systematic algorithm for the development
of peptide affinity reagents. This algorithm does not require large
libraries or structural information, which are important charac-
Figure 6. SDS-PAGE analysis of TNF1 and TNF1-opt pull-down
assays. Silver-stained gel image of the final eluted fraction from TNF-a
pull-down assays performed with immobilized TNF1 and TNF1-opt in
the presence of excess E.coli lysate (,2 mg/mL). Purified 10 mM TNF-a
and the TNF-a spiked E.coli lysate used in the pull-down assay are also
shown. Several bands appear on the gel independent of the
immobilized peptide and are indicated with an asterisk (*), these bands
are attributed to background bead binding. After subtracting
background bands, one additional off-target band at approximately
65 kDa that appears in the TNF1-opt pull-down eluted fraction is noted.
(Bottom) The band near 17 kDa in the SDS-PAGE image was validated
as TNF-a with a Western blot.
doi:10.1371/journal.pone.0015432.g006
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peptide ligands and differentiate this algorithm from other affinity
reagent development approaches. Initially, a sparse sampling of
random 20-mer peptide sequence space was screened for low-
affinity lead peptides. After lead identification, the low-affinity
peptides were optimized to high-affinity in only two steps by first
screening restricted-diversity point-variant libraries, and second
combining affinity-enhancing sequence variations to achieve
thermodynamically additive binding affinity gains (Figure 1).
General applicability to several protein targets has been shown,
and binding dissociation constant (Kd) enhancements of nearly
250-fold were achieved with this algorithm (Table S3 in File S1).
In one specific example, the TNF4-opt peptide developed with this
algorithm is one of the highest affinity TNF-a binding peptides/
small-molecules reported to-date [28–30,41].
While a comprehensive analysis of enthalpy/entropy contribu-
tions of variations in short unstructured peptides warrants a
dedicated publication, this work provides insight into the effect of
sequence variation on protein-peptide binding thermodynamics
and specificity. First, in most cases tested, the effect of combining
sequence variations was additive with respect to binding energy
(Table 2, Tables S3, S5 in File S1). Exception to this was observed
when the combined point-variations were nearest neighbors, in
which case, the affinity gains were less than what would be
expected from thermodynamic additivity. This deviation from
additivity is presumably due to nearest neighbor interactions that
interfere with independent contributions by each variation
[17,20]. It is also possible, in principle, for nearest neighbor
interactions to result in cooperative gains, thereby improving
affinity beyond what would be predicted by thermodynamic
additivity, such cooperative interactions were not observed here.
Based on the lead peptides tested, it appears that higher lead
peptide affinity produces higher affinity in an optimized sequence
containing multiple ehancing point variations. Also, the somewhat
less than additive affinity gains achieved with TNF4-opt, which
was derived from the highest lead starting affinity (TNF4,
Kd=2363.5 mM for TNF-a), suggest that additivity in a 20-mer
peptide starts to break down as the affinity approaches the low
nanomolar range (Table S3 in File S1). One explanation for this is
that as additional contact points between the peptide and protein
are added, the peptide becomes increasingly sterically constrained,
making it impossible to add further contact points that are
structurally independent [17,20,42]. A potentially powerful
strategy to overcome this apparent affinity barrier is to combine
this additivity algorithm with recently described multivalent
peptide affinity reagent approaches [31,43].
Both microarray-based and bead-based pull-down specificity
studies show that TNF1-opt and TNF4-opt bind TNF-a with high
specificity when challenged with E.coli lysate as a competive
mixture (Figure 6, Figure S10 in File S1). Pull-down assays
identified only one additional off-target E.coli protein bound by the
optimized peptides when compared to the leads. This suggests that
the additive affinity enhancements are not purely due to non-
specific effects. Several possible explanations for the optimized
variants binding to a single additional off-target protein exist. First
the variations introduced into the optimized sequences could have
produced a new binding motif in the peptides that have ‘specific’
affinity for a single E.coli protein. Second, it is possible E.coli
protein(s) exist that contain binding surfaces(s) analogous to
binding surface(s) on TNF-a and enhancing TNF-a binding site
affinity also enhances affinity for analogous sites on E.coli
protein(s). Finally, variant peptide binding to TNF-a may modify
the surface of TNF-a in such a way that promotes an interaction
between TNF-a and specific E.coli protein(s). Due to the distinct
nature of binding affinity and specificity [44,45], achieving
significant gains in affinity as well as target specificity may be
possible by simultaneously screening point-variants for both
affinity and specificity enhancement before combining them into
an optimized variant.
From the microarray binding experiments, it is worth noting
that the ranked fluorescently labeled TNF-a binding intensities for
TNF1 and all variants on the microarray (Table S2 in File S1)
agree very well with the ranked affinities of the same peptides
determined by SPR (Tables 1, 2). This demonstrates that short
peptides screened and optimized in solution-phase assays such as
SPR can show comparable target binding behavior when
immobilized on a microarray surface [46], a potentially very
useful characteristic when designing affinity reagents for purifica-
tion or diagnostics.
The additivity algorithm described here provides several distinct
advantages for affinity reagent development. First, without the use
of enzymes to create the libraries, there is unbiased sequence
selection/optimization [20], and this approach could be applied to
natural/non-natural heteropolymers under a diverse range of
conditions. Second, through judicious combination of point
variations, specific properties of the final affinity reagent, such as
solubility, tendency to aggregate, or performance in a particularly
assay format, can be maintained or improved throughout the
optimization process. Third, since this algorithm utilizes a screen,
rather than a selection, both enhanced and reduced affinity
variants can be quantified, providing significantly more informa-
tion about the binding interaction when compared to a selection
that only produces a small set of the highest affinity sequences.
Finally, this approach uses a relatively small amount of target
protein and is amenable to high-throughput application and
automation, which is very important for producing a library of
affinity reagents to the proteome. Because this is a systematic
algorithm, one could envision an automated system that starts with
a target protein, generates a lead sequence from a sparse random
library, optimizes the peptide via thermodynamic additivity and
outputs an optimized sequence.
Methods
Peptide SPR Screen
A library of 10
4 20-mer random sequence peptides was screened
as a series of 4 experiments using a Biacore A100 (GE Healthcare,
Piscataway, NJ) high-throughput surface plasmon resonance (SPR)
system, with ,2500 peptides screened in each experiment. Four
peptides were flowed separately, in parallel, through four SPR flow
cells with 5 proteins immobilized as addressable spots in each flow
cell (a total of 20 addressable spots). Peptide binding was analyzed
with a 60-second association phase followed by a 60-second
dissociation phase. Reference subtracted SPR sensorgrams were
recorded for each peptide at all protein spots, in all flow cells, on
the SPR chip. Surface regeneration was performed after every 15
injections in each flow cell with Biacore Glycine 2.5 regeneration
solution (GE Healthcare, Piscataway, NJ).
Lead Identification
Lead peptides with TNF-a affinity were identified after a series
of validation steps following the random peptide library screen.
First, 171 potential lead peptides were screened for acceptable
sample purity using MALDI-MS, those with purity less than 70%
were discarded. The remaining potential lead peptides were
further filtered by comparing TNF-a SPR binding response to the
binding response from three unrelated proteins on the SPR chip as
well as the response from the neutravidin coated reference spot.
Additivity of Peptide Sequence Variations
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off-target proteins were discarded. Finally, the remaining 10 leads
were subjected to a second SPR affinity assay using a series of
peptide concentrations. From this, two lead peptides, TNF1 and
TNF4, were identified.
Point-Variant Library and SPR Chip Preparation
Point-variant libraries were prepared in 96-well stock plates as
described in the supporting information. From the stock plate,
peptides were diluted to 50 mMo r1 0mM in Biacore HBS-EP
buffer (GE Healthcare, Piscataway, NJ) containing 1 mg/ml
carboxymethyl-dextran (Sigma-Aldrich, St. Louis, MO) to reduce
non-specific binding to the CM-5 SPR chip surface. Biotinylated
TNF-a was captured on a neutravidin coated Biacore CM-5 chip
(GE Healthcare, Piscataway, NJ) at different levels on spots 1, 2, 4,
and 5 across all four flow cells corresponding to a low to moderate
Rmax range of 40-200 RU. Spot 3 on all flow cells contained only
immobilized neutravidin and served as a reference spot.
Point-Variant SPR Screen
Using the prepared 96-well plates and Biacore A100 SPR
system, four peptides were flowed separately, in parallel, through
the four flow cells over all 4 TNF-a spots and the neutravidin
reference spot (16 TNF-a, 4 neutravidin spots total), with a 60-
second association phase and 300-second dissociation phase.
Reference subtracted SPR sensorgrams were recorded for each
peptide from all TNF-a spots. Surface regeneration was performed
after every 12 injections in each flow cell with Biacore Glycine 2.5
regeneration solution. Point-variant reference subtracted, peptide
molecular weight adjusted, responses at the late binding region of
the sensorgram (a few seconds before dissociation) were compared
to the response of the lead.
Enhanced Point-Variant Characterization
Affinities of several enhanced point-variants identified from the
point-variant screen were determined by SPR using equilibrium
binding responses across a series of peptide concentrations on an
SPR chip containing varying levels of immobilized TNF-a with a
predicted Rmax range of 40-120 RU. Responses were normalized
to the predicted Rmax so that results from different TNF-a capture
levels could be directly compared.
Multiple Variant Characterization
Sequences containing multiple enhancing point variations were
synthesized using standard solid-phase synthesis and purified.
Multiple variant affinities were determined with the same protocol
used for point-variant affinities.  (PDF)
Calculation of Binding Energies and Dissociation
Constants
Peptide binding energies and dissociation constants (Kd) were
calculated separately as a mean and standard error of all replicate
measurements. Therefore, the reported standard free energies of
binding and dissociation constants may deviate slightly from direct
calculation using the reported values. For multiple variants,
predicted binding energies are reported as a range to account for
the error in the observed values used to calculate the predicted
value.
Additional experimental details are available in the supporting information
(Text S1 in File S1).
Supporting Information
File S1 Additional figures, tables and experimental
methods.
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